These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 14611841)
21. The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE. Levin JI Curr Top Med Chem; 2004; 4(12):1289-310. PubMed ID: 15320727 [TBL] [Abstract][Full Text] [Related]
22. Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity. Ledour G; Moroy G; Rouffet M; Bourguet E; Guillaume D; Decarme M; Elmourabit H; Augé F; Alix AJ; Laronze JY; Bellon G; Hornebeck W; Sapi J Bioorg Med Chem; 2008 Sep; 16(18):8745-59. PubMed ID: 18782669 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors. Santos MA; Marques SM; Tuccinardi T; Carelli P; Panelli L; Rossello A Bioorg Med Chem; 2006 Nov; 14(22):7539-50. PubMed ID: 16875829 [TBL] [Abstract][Full Text] [Related]
24. Quantitative structure-activity relationship studies on matrix metalloproteinase inhibitors: hydroxamic acid analogs. Gupta SP; Kumaran S Med Chem; 2006 May; 2(3):243-50. PubMed ID: 16948470 [TBL] [Abstract][Full Text] [Related]
25. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis. Nuti E; Casalini F; Avramova SI; Santamaria S; Cercignani G; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Tuccinardi T; Martinelli A; Lim NH; Visse R; Nagase H; Rossello A J Med Chem; 2009 Aug; 52(15):4757-73. PubMed ID: 19606871 [TBL] [Abstract][Full Text] [Related]
26. Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships. Duan JJ; Chen L; Wasserman ZR; Lu Z; Liu RQ; Covington MB; Qian M; Hardman KD; Magolda RL; Newton RC; Christ DD; Wexler RR; Decicco CP J Med Chem; 2002 Nov; 45(23):4954-7. PubMed ID: 12408705 [TBL] [Abstract][Full Text] [Related]
27. First insight into structure-activity relationships of selective meprin β inhibitors. Ramsbeck D; Hamann A; Schlenzig D; Schilling S; Buchholz M Bioorg Med Chem Lett; 2017 Jun; 27(11):2428-2431. PubMed ID: 28408220 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket. Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812 [TBL] [Abstract][Full Text] [Related]